Acute Respiratory Viral Serology Array
Acute Respiratory Viral Serology Array

- Available as complete respiratory viral serology array and as a COVID-19 focus Array
- Utilizes Adarza’s AIR technology for high sensitivity and multiplex
Notify me when new assays are launched.
We're happy to help you complete our purchase.
To get started now, just give us a call at
1-314-925-7800
Or complete the form below.
Specifications:
Analytes:
Influenza A Wisconsin H3N2
The influenza viral Hemagglutinin (HA) protein is a homo trimer with a receptor binding pocket on the globular head of each monomer. It is derived from the H3N2 Influenza A Wisconsin-2005 origin.
Influenza A Texas H3N2
The influenza H3N2 HA1 subunit is a subunit of the viral Hemagglutinin (HA) protein. It is derived from the H3N2 Influenza A Texas-2012 origin.
Influenza A California H1N1
The influenza viral Hemagglutinin (HA) protein is a homo trimer with a receptor binding pocket on the globular head of each monomer. It is derived from the H1N1 Influenza A California-2009 origin.
Influenza A Beijing H1N1
The influenza H1N1 HA1 subunit is a subunit of the viral Hemagglutinin (HA) protein. It is derived from the H1N1 Influenza A Beijing-2009 origin.
Influenza A Shanghai H7N9
The influenza viral Hemagglutinin (HA) protein is a homo trimer with a receptor binding pocket on the globular head of each monomer. It is derived from the H7N9 Influenza A Shanghai-2013 origin.
Influenza A Vietnam H5N1
The influenza H5N1 HA1 subunit is a subunit of the viral Hemagglutinin (HA) protein. It is derived from the H5N1 Influenza A Vietnam-2004 origin.
Influenza B Massachusetts
The influenza B viral Hemagglutinin (HA) protein is a homo trimer with a receptor binding pocket on the globular head of each monomer. It is derived from the Influenza B Massachusetts-2010 origin.
Influenza B Phuket
The influenza B viral Hemagglutinin (HA) protein is a homo trimer with a receptor binding pocket on the globular head of each monomer. It is derived from the Influenza B Phuket-2013 origin.
Influenza B Malaysia
The influenza B viral Hemagglutinin (HA) protein is a homo trimer with a receptor binding pocket on the globular head of each monomer. It is derived from the Influenza B Malaysia-2013 origin.
CoV-HKU1 S1
The spike (S) glycoprotein of coronaviruses consists of the S1, S2 regions. The S1 region, which is responsible for the initial attachment of the virus HcoV-HKU1 to the surafce of host cells, is specifically targeted.
CoV-229E S1 + S2
The spike (S) glycoprotein of coronaviruses consists of the S1, S2 regions. The S1 region is responsible for the initial attachment of the virus HcoV-229E to the surface of host cells and the S2 region is responsible for membrane fusion that triggers the entry of the virus into host cells. Both the S1 and S2 region of HCoV-229E strain are specifically targeted.
CoV-OC43 S1+ S2
The spike (S) glycoprotein of coronaviruses consists of the S1, S2 regions. The S1 region is responsible for the initial attachment of the virus HcoV-OC43 to the surface of host cells and the S2 region is responsible for membrane fusion that triggers the entry of the virus into host cells. Both the S1 and S2 region of HCoV-OC43 strain are specifically targeted.
CoV-NL63 S1
The spike (S) glycoprotein of coronaviruses consists of the S1, S2, and RBD regions. The S1 region of the strain HcoV-NL63 is specifically targeted.
SARS-CoV-2 Spike RBD Mutation D614G
The spike (S) glycoprotein of coronaviruses consists of the S1, S2 regions. The S1 region, which is responsible for the initial attachment of the virus SARS-CoV-2 (COVID-19) mutant D614G to the surface of host cells, is specifically targeted.
SARS-CoV-2 S1
The spike (S) glycoprotein of coronaviruses consists of the S1, S2 regions. The S1 region, which is responsible for the initial attachment of the virus SARS-CoV-2 (COVID-19) to the surface of host cells, is specifically targeted.
SARS-CoV-2 RBD
The spike (S) glycoprotein of coronaviruses consists of the S1, S2 regions. The S1 region is responsible for the initial attachment of the virus SARS-CoV-2 (COVID-19) to the surface of host cells and the S2 region is responsible for membrane fusion that triggers the entry of the virus into host cells. The S1 contains a receptor binding domain (RBD) and is critical in attachment of the virus to host cells. The RBD is specifically targeted.
SARS-CoV-2 Nucleocapsid
Coronaviruses are enveloped viruses with a positive-sense RNA genome and with a nucleocapsid of helical symmetry. Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. This Nucleocapsid is from the SARS-CoV-2 (COVID-2019).
SARS-CoV-2 S1 + S2
The spike (S) glycoprotein of coronaviruses consists of the S1, S2 regions. The S1 region is responsible for the initial attachment of the virus SARS-CoV-2 (COVID-19) to the surface of host cells and the S2 region is responsible for membrane fusion that triggers the entry of the virus into host cells. Both the S1 and S2 region of SARS-CoV-2 ECD mutant strain are specifically targeted.
SARS-CoV-2 S2
The spike (S) glycoprotein of coronaviruses consists of the S1, S2 regions. The S2 region is responsible for membrane fusion that triggers the entry of the virus into host cells. A mutant of the S2 region of the strain SARS-CoV-2 (COVID-19) is specifically targeted.
MERS-CoV S1
The spike (S) glycoprotein of coronaviruses consists of the S1, S2 regions. The S1 region, which is responsible for the initial attachment of the virus MERS-CoV is specifically targeted.
MERS-CoV RBD
The spike (S) glycoprotein of coronaviruses consists of the S1, S2 regions. The S1 region is responsible for the initial attachment of the virus MERS-CoV to the surface of host cells and the S2 region is responsible for membrane fusion that triggers the entry of the virus into host cells. The S1 contains a receptor binding domain (RBD) and is critical in attachment of the virus to host cells. The RBD is specifically targeted.
MERS-CoV Nucleocapsid
Coronaviruses are enveloped viruses with a positive-sense RNA genome and with a nucleocapsid of helical symmetry. Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. This Nucleocapsid is from the MERS-CoV virus.
SARS-CoV S1
The spike (S) glycoprotein of coronaviruses consists of the S1, S2 regions. The S1 region, which is responsible for the initial attachment of the virus SARS-CoV to the surafce of host cells, is specifically targeted.
SARS-CoV RBD
The spike (S) glycoprotein of coronaviruses consists of the S1, S2 regions. The S1 region, which is responsible for the initial attachment of the virus SARS-CoV to the surafce of host cells, is specifically targeted.
SARS-CoV Nucleocapsid
The spike (S) glycoprotein of coronaviruses consists of the S1, S2 regions. The S1 region, which is responsible for the initial attachment of the virus SARS-CoV to the surface of host cells, is specifically targeted.
RSV A G Protein
Human respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. HRSV has two major surface glycoproteins (G and F) that play important roles in the initial stages of the infectious cycle. The G protein mediates attachment of the virus to the host cell membrane by interacting with heparan sulfate, initiating the infection. Secreted glycoprotein G helps RSV escape antibody-dependent restriction of replication by acting as an antigen decoy and by modulating the activity of leukocytes bearing Fcgamma receptors.
RSV B G Protein
Human respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. HRSV has two major surface glycoproteins (G and F) that play important roles in the initial stages of the infectious cycle. The G protein mediates attachment of the virus to the host cell membrane by interacting with heparan sulfate, initiating the infection. Secreted glycoprotein G helps RSV escape antibody-dependent restriction of replication by acting as an antigen decoy and by modulating the activity of leukocytes bearing Fcgamma receptors.
Kit Contents
Reagent | Volume | Quantity | Storage |
---|---|---|---|
96 well consumable with biosensor array | N/A | 1 | 4˚C |
Clear Plate Seal | 1 | 1 | RT |
Plate Lid | 1 | 1 | RT |
Negative Control | 100µl | 1 | 4°C |
Positive Control* | 25µl | 1 | 4°C |
Assay Buffer | 16ml | 1 | 4˚C |
ZIVA™ Wash Buffer (ZWB) | 50ml of 20X | 1 | 4˚C |
Resources & Data


